Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV- 1 viruses

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 2, 1999, Pages 115-121

  Peeters, Martine ^a   Vincent, Rachel ^a   Perret, Jean Luc ^b   Lasky, Mariama ^a   Patrel, Delphine ^a   Liegeois, Florian ^a   Courgnaud, Valerie ^a   Seng, Remoni ^c   Matton, Thierry ^a   Molinier, Sylvain ^b   Delaporte, Eric ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b LAVERAN MILITARY TEACHING HOSPITAL   (France)

^c Leon Mba   (France)

Author keywords

Genetic subtypes of HIV 1; MT2 cell tropism; Syncytium inducing variants

Indexed keywords

ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; STRAIN DIFFERENCE; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS ISOLATION;

EID: 0033081870     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199902010-00002     Document Type: Article

References (46)

1. Meyers G, Korber B, Hahn B, et al. Human retroviruses and AIDS 1995: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM, Los Alamos National Laboratory, 1995.
2. Janssens W, Buvé A, Nkengasong J. The puzzle of HIV-1 subtypes in Africa. AIDS 1997;11:705-12.
3. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346:1198-9.
4. Lasky M, Peret JL, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997;11:43-51.
5. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
6. Barin F, Courouce AM, Pillonel J, et al. Increasing diversity of HIV-1 M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 1997;11:1503-8.
7. Asjo B, Albert J, Karlsson L, et al. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;2:660-2.
8. Cheng-Mayer C, Seto D, Tateno M, Levy J. Biologic features of HIV-1 that correlate with virulence in the host. Science 1988;240: 80-2.
9. Koot M, Vos A, Keet R, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
10. Tersmette M, De Goede REY, AI B, et al. Differential syncytium-inducing capacity of human immunodeficiency isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988;62:2026-32.
11. Schuitemaker H, Koot M, Kootstra N, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to Tcell tropic virus populations. J Virol 1992;66: 1354-60.
12. Fenyo EM, Mortfeldt-Manson L, Chiodi F, et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-19.
13. Tersmette M, Gruters RA, De Wolf, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989;63:2118-25.
14. 4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
15. Karlsson A, Parsmyr K, Aperia K, Sandstrom E, Fenyo E, Albert J. MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. J Infect Dis 1994;170:1367-75.
16. Choe H, Farzan M, Sun Y, et al. The B-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
17. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-6.
18. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman H, Miedema F, Schuitemaker H. Phenotype-assocoated sequence variation in the third variable region of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992;66:3183-7.
19. De Jong J, De Rond A, Keulen W, Tersmette M, Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino-acid substitution. J Virol 1992;66:6777-6780.
20. Zhang L, Huang Y, He T, Cao Y, Ho D. HIV-1 subtype and second-receptor use. Nature 1996;383:768.
21. Doms R, Moore J. HIV-1 coreceptor use: a molecular window into viral tropism. Los Alamos, NM: Los Alamos Database, 1997.
22. Tsherning C, Alaeus A, Frederiksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-8.
23. Glushakova S, Grivel JC, Fitzgerald W, Sylwester A, Zimmerberg J, Margolis L. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 1998;4:346.
24. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of env genes. Science 1993;262:1257-61.
25. De Wolf F, Hogervorst E, Goudsmit J, et al. Syncytium inducing and non-syncyyium inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994;10:1387-1400.
26. Fouchier R, Brouwer M, Broersen S, Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Micmbiol 1995;33:906-11.
27. Sabri F, Chiodi F, Fenyo E. Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates. AIDS Res Hum Retroviruses 1996;12:855-8.
28. Holm-Hansen C, Grothues, Rustad S, Rosok B, Rodica Pascu F, Asjo B. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Res Hum Retroviruses 1995;11:597-603.
29. Groenink M, Fouchier R, Broersen S, et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993; 260:1513-15.
30. Andeweg A, Leeflang P, Osterhaus A, Bosch M. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. J Virol 1993:3232-9.
31. Stamatos L, Cheng-Mayer C. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range and syncytium formation ability. J Virol 1993;67:5635-9.
32. Freed EO, Martin MA. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 glycoprotein gp120. J Virol 1994;68:2503-12.
33. Kuiken C, De Jong J, Baan E, Keulen W, Tersmette M, Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the biological phenotype. J Virol 1992;66:4622-7.
34. Yu X, Wang Z, Beyrer C, et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in Northern Thailand. J Virol 1995;69:4649-55.
35. Kanki P, Travers K, Mboup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-6.
36. De Cock K, Adjorlo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993; 270:2083-6.
37. Marlink R, Kanki P, Thior I, et al. Reduced rates of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-90.
38. Kalebu P. Relationship between clinical outcome and viral sequences. Presented at the Workshop on HIV-1 Subtypes: Implications for Epidemology, Pathogenicity, Vaccines and Diagnostics, Dar Es Salaam, Tanzania 1997.
39. Soto-Ramirez L, Renjifo B, Mc Lane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-3.
40. Dittmar M, Simmons G, Hibbitts S, et al. Langerhans cell tropism of HIV-1 subtype A trough F isolates derived from different transmission groups. J Virol 1997;71:8008-13.
41. Pope M, Frankel S, Mascola J, et al. HIV-1 strains from subtype B and E replicate in cutaneous dendritic cell-T cell mixtures without displaying subtype-specific tropism. J Virol 1997;71:8001-7.
42. Kunanosont C, Foy H, Kreiss J, et al. HIV-1 subtypes and male to female transmission in Thailand. Lancet 1995;345:1078-83.
43. Van Harmelen J, Wood R, Lambrinck M, et al. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997;11:81-7.
44. Cornelissen M, Mulder-Campinga G, Veenstra J, et al. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 1995;69:1810-18.
45. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261:1179-81.
46. Workshop report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. AIDS 1997;11:17-36.